Skip to main content
. 2017 Feb 26;18(3):505. doi: 10.3390/ijms18030505

Figure 1.

Figure 1

After different weeks of treatment with oral prednisone, levels of serum proteasome 20S were evaluated by ELISA test (Proteasome Elisa kit BML-PW057-0001, Enzo Life Science, Rome, Italy), while levels of ubiquitin and MAb-FK1 were evaluated by Western blotting with specific primary antibodies (anti-ubiquitin sc-8017, Santa Cruz Biotechnology, Heidelberg, Germany; anti-FK1 BML-PW8805-0500, Enzo Life Science, Rome, Italy) and anti-mouse secondary antibody (sc-2005, Santa Cruz Biotechnology, Heidelberg, Germany). Week 0 represents the acute attack of uveitis and the initiationof the prednisone therapy. Values are the means ± S.E.M. of three measurements for each time point. * p < 0.01 vs. control; ο p < 0.05 vs. week 0; οο p < 0.01 vs. week 0.